Transdermal Drug Delivery System Market - Global Market Share, Trends, Analysis and Forecast, 2023-2032
The global transdermal drug delivery system market size was estimated to be US$ 5.5 billion in 2021 and is expected to grow at a CAGR of 6.3% between 2023 to 2032.
Transdermal drug delivery is a method of drug administration wherein the drugs are delivered through the skin to achieve systemic dispersion across the entire body. Transdermal drug delivery systems work as a type of controlled release mechanism in which medications are given through the skin at a specified and regulated pace. Transdermal drug delivery technologies are used to treat a variety of diseases, including cardiovascular illnesses and neurological problems.
Some of the drugs supplied using transdermal skin patches are nicotine (for smoking cessation), nitro-glycerine (for angina), scopolamine (for motion sickness), and lidocaine (for shingles pain), among others. These products have several advantages, including a longer therapeutic impact, fewer adverse effects, increased bioavailability, improved patient compliance, and simple drug therapy discontinuation. The appendageal, transcellular, and intercellular channels are the three primary ways of drug entry using the transdermal drug delivery system.
Transdermal Drug Delivery System Market Growth Drivers:
Growing number of geriatric patients across the world is driving the market growth
The growing number of geriatric patients across the world and the increase in chronic ailments such as musculoskeletal diseases and aging disorders among the elderly are driving up the market for skin-based drug patches. Furthermore, transdermal drug delivery systems provide various advantages such as improved safety, efficiency, and decreased inter-patient variation of dosages. All of these factors are significantly driving the growth of the global transdermal drug delivery systems market.
The increase in the demand for drug self-administration for patients with long-term ailments is among the primary growth drivers for global transdermal drug delivery systems products. It is predicted that the transdermal drug delivery systems market would see new demands as the mobile/online health segment develops. As patients start to realize the available choices the benefits of such systems might aid market expansion for transdermal drug delivery systems.
Increased preference of patients for pain-free drug administration is also predicted to enable a greater acceptance of adhesive skin patches which will help to fuel the growth of the transdermal drug delivery systems market. this feature will also offer revenue-generating opportunities for leading industry participants during the forecasted period.
Advances in conventional pharmaceutical delivery systems with a rising emphasis on skin-based drug delivery are projected to fuel demand and contribute to the overall growth of this market. Other factors, such as advancements in the customized health management sector with the introduction of advanced materials and enhanced features will help patients and help the transdermal drug delivery category to emerge as one of the top revenue producers in the future.
Despite all of the foregoing development opportunities, the high cost of transdermal patches as compared to other conventional treatment options, as well as poor penetration in emerging regions will limit the transdermal drug delivery system's market growth.
Primary user and product segmentation:
During the projection period, the pain management category is expected to have the greatest share of the market in transdermal drug delivery system products. One of the primary factors driving the segment's growth in the global market is the increased use of opioid medicine patches in pain treatment, particularly among cancer patients.
Because of the increased need for transdermal drug delivery systems to treat patients suffering from various ailments, the hospital sector is likely to provide the most revenue to the global transdermal drug delivery market during the forecast period of our report.
Regional Trends of the Global Transdermal Drug Delivery System Market
North America dominated the transdermal drug delivery system devices market until now, and this dominance is expected to remain at the top spot throughout the forecast period. The increased frequency of conditions such as chronic pain, cancer, and cardiovascular disease, as well as research efforts done by market participants to offer new products in the region, are major factors linked to the leadership position.
Because of increased chronic disease prevalence and expanding disease awareness in both developed and emerging markets like China and India, Asia Pacific is predicted to be the highest revenue-generating region in the global market. Because of established healthcare infrastructure facilities in nations such as the United Kingdom and Germany, Europe is also expected to see high growth in the global transdermal drug delivery systems market during the forecast years.
Increased healthcare expenditure, rising medical consciousness, and growing investments by different regional players in the creation of innovative patches are some of the drivers driving the continent's expansion of the transdermal drug delivery systems market.
Other parts of the world, such as Latin America, the Middle East, and Africa, are likely to have modest growth in the total transdermal drug delivery systems market in the forecast period, due to the lack of well-established market participants in these regions.
Competitive practices and global players:
The global transdermal drug delivery systems market is extremely competitive, with many major competitors present in all regions. Many of these firms are likely to be responsible for a sizable portion of the overall market in the future. Prominent market players may get into collaboration arrangements with smaller competitors to boost their market position and profit margin.
Leading market firms may also invest in the mobile and online health category, allowing it to emerge as the fastest-expanding market in the next years. In the approaching years, R&D projects might be a crucial revenue-generating business strategy for big players in the transdermal drug delivery system market.
Some of the major players present in the transdermal drug delivery system market are 3M, Mylan, AdhexPharma, DuPont, Endo International, Lubrizol Corporation, Novartis AG, Purdue Pharma L.P., and others.
Global Transdermal Drug Delivery System Market Segmentation:
By Type
- Patches
- Gels
By Application
- Pain Management
- Cardiovascular Diseases
- Central Nervous System Disorders
- Other
By End User
- Hospitals
- Clinics
- Home Care
- Others
By Geography
- North America
- United States
- Canada
- Rest of North America
- Europe
- Germany
- United Kingdom
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- India
- China
- Australia
- Rest of Asia Pacific
- Middle East & Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of the Middle East & Africa
- South America
- Brazil
- Rest of South America
- Introduction
- Research Objectives
- Report Assumptions
- Research Methodology
- Abbreviations
- Preface
- Market Definition
- Report Scope and Market Segmentation
- Research Highlights
- Market Synopsis: Global Transdermal Drug Delivery System Market
- Global Transdermal Drug Delivery System Market Qualitative Analysis
- Trends
- Market trends
- Technology Trends
- PESTLE Analysis (For 3 prominent countries)
- Market Influencers
- Driving Forces
- Hindering Forces
- Opportunities
- COVID-19 impact
- Porter’s Five Forces Analysis
- Value Chain Analysis
- Trends
- Global Transdermal Drug Delivery System Market Analysis and Forecast, by Type
- Overview and definitions
- Key segment analysis
- Global Transdermal Drug Delivery System Market Estimates (US$ Mn), Type, 2019 – 2032
- Patches
- Matrix Patches
- Microneedle Patches
- Drug-In-Adhesive Patches
- Reservoir Membrane Patches
- Transdermal Semisolids
- Sprays
- Gels
- Ointments
- Patches
- Global Transdermal Drug Delivery System Market Analysis and Forecast, by Application
- Overview and definitions
- Key segment analysis
- Global Transdermal Drug Delivery System Market Estimates (US$ Mn), Application, 2019 – 2032
- Pain Management
- Cardiovascular Diseases
- Hormonal applications
- Central Nervous System Disorders
- Other applications
- Global Transdermal Drug Delivery System Market Analysis and Forecast, by End Use
- Overview and definitions
- Key segment analysis
- Global Transdermal Drug Delivery System Market Estimates (US$ Mn), by End Use, 2019 – 2032
- Hospitals
- Clinics
- Home Care
- Others
- Global Transdermal Drug Delivery System Market Analysis and Forecast, by Region
- Overview and definitions
- Key segment analysis
- Global Transdermal Drug Delivery System Market Estimates (US$ Mn), by Region, 2019 – 2032
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- South America
- North America Transdermal Drug Delivery System Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- North America Transdermal Drug Delivery System Market Estimates (US$ Mn), Type, 2019 – 2032
- Patches
- Matrix Patches
- Microneedle Patches
- Drug-In-Adhesive Patches
- Reservoir Membrane Patches
- Transdermal Semisolids
- Sprays
- Gels
- Ointments
- North America Transdermal Drug Delivery System Market Estimates (US$ Mn), Application, 2019 – 2032
- Pain Management
- Cardiovascular Diseases
- Hormonal applications
- Central Nervous System Disorders
- Other applications
- North America Transdermal Drug Delivery System Market Estimates (US$ Mn), by End Use, 2019 – 2032
- Hospitals
- Clinics
- Home Care
- Others
- North America Transdermal Drug Delivery System Market Estimates (US$ Mn), by Country, 2019 – 2032
- United States
- Canada
- Rest of North America
- Patches
- Europe Transdermal Drug Delivery System Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- Europe Transdermal Drug Delivery System Market Estimates (US$ Mn), Type, 2019 – 2032
- Patches
- Matrix Patches
- Microneedle Patches
- Drug-In-Adhesive Patches
- Reservoir Membrane Patches
- Transdermal Semisolids
- Sprays
- Gels
- Ointments
- Europe Transdermal Drug Delivery System Market Estimates (US$ Mn), Application, 2019 – 2032
- Pain Management
- Cardiovascular Diseases
- Hormonal applications
- Central Nervous System Disorders
- Other applications
- Europe Transdermal Drug Delivery System Market Estimates (US$ Mn), by End Use, 2019 – 2032
- Hospitals
- Clinics
- Home Care
- Others
- Europe Transdermal Drug Delivery System Market Estimates (US$ Mn), by Country, 2019 – 2032
- Germany
- United Kingdom
- Italy
- France
- Spain
- Rest of Europe
- Patches
- Asia Pacific Transdermal Drug Delivery System Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- Asia Pacific Transdermal Drug Delivery System Market Estimates (US$ Mn), Type, 2019 – 2032
- Patches
- Matrix Patches
- Microneedle Patches
- Drug-In-Adhesive Patches
- Reservoir Membrane Patches
- Transdermal Semisolids
- Sprays
- Gels
- Ointments
- Asia Pacific Transdermal Drug Delivery System Market Estimates (US$ Mn), Application, 2019 – 2032
- Pain Management
- Cardiovascular Diseases
- Hormonal applications
- Central Nervous System Disorders
- Other applications
- Asia Pacific Transdermal Drug Delivery System Market Estimates (US$ Mn), by End Use, 2019 – 2032
- Hospitals
- Clinics
- Home Care
- Others
- Asia Pacific Transdermal Drug Delivery System Market Estimates (US$ Mn), by Country, 2019 – 2032
- China
- Japan
- South Korea
- India
- Australia
- Rest of Asia Pacific
- Patches
- Middle East & Africa Transdermal Drug Delivery System Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- Middle East & Africa Transdermal Drug Delivery System Market Estimates (US$ Mn), Type, 2019 – 2032
- Patches
- Matrix Patches
- Microneedle Patches
- Drug-In-Adhesive Patches
- Reservoir Membrane Patches
- Transdermal Semisolids
- Sprays
- Gels
- Ointments
- Middle East & Africa Transdermal Drug Delivery System Market Estimates (US$ Mn), Application, 2019 – 2032
- Pain Management
- Cardiovascular Diseases
- Hormonal applications
- Central Nervous System Disorders
- Other applications
- Middle East & Africa Transdermal Drug Delivery System Market Estimates (US$ Mn), by End Use, 2019 – 2032
- Hospitals
- Clinics
- Home Care
- Others
- Middle East & Africa Transdermal Drug Delivery System Market Estimates (US$ Mn), by Country, 2019 – 2032
- UAE
- Saudi Arabia
- South Africa
- Rest of MEA
- Patches
- South America Transdermal Drug Delivery System Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- South America Transdermal Drug Delivery System Market Estimates (US$ Mn), Type, 2019 – 2032
- Patches
- Matrix Patches
- Microneedle Patches
- Drug-In-Adhesive Patches
- Reservoir Membrane Patches
- Transdermal Semisolids
- Sprays
- Gels
- Ointments
- South America Transdermal Drug Delivery System Market Estimates (US$ Mn), Application, 2019 – 2032
- Pain Management
- Cardiovascular Diseases
- Hormonal applications
- Central Nervous System Disorders
- Other applications
- South America Transdermal Drug Delivery System Market Estimates (US$ Mn), by End Use, 2019 – 2032
- Hospitals
- Clinics
- Home Care
- Others
- South America Transdermal Drug Delivery System Market Estimates (US$ Mn), by Country, 2019 – 2032
- Brazil
- Argentina
- Rest of South America
- Patches
- Competition Analysis – Global Transdermal Drug Delivery System Market
- Market Composition
- Market Share Analysis (%), by Supplier (2022)
- Company Profiles
- Novartis Ag
- Business overview
- Geographic presence
- Product portfolio
- Financial facts
- Relevant news and strategic view
- Johnson & Johnson Services, Inc.
- Glaxosmithkline Plc.
- Bayer Ag
- Mylan N.V.
- Boehringer Ingelheim International Gmbh
- Hisamitsu Pharmaceutical Co.,Inc.
- Luye Pharma Group
- Purdue Pharma L.P.
- Lavipharm
- Novartis Ag
- Conclusion & Recommendations
Frequently asked questions about this report
What is the transdermal drug delivery system market growth?
The global transdermal drug delivery system market is geared to grow at a CAGR of 6.3% from 2023 to 2032.
What are the factors promoting the growth of global transdermal drug delivery system market?
Increase in the demand for drug self-administration by patients with long-term ailments is among the primary growth drivers for global transdermal drug delivery systems market.
What are the major limitations for the global transdermal drug delivery system market?
The high cost of transdermal patches when compared to other conventional treatment options and poor penetration in under developed regions will limit the market growth for Transdermal Drug Delivery System.
What was the market for transdermal drug delivery system valued at in 2021?
Transdermal drug delivery system market size was estimated to be US$ 5.5 billion in 2021.
Who are the top players in the global transdermal drug delivery system market?
3M, Mylan, AdhexPharma, DuPont, Endo International, Lubrizol Corporation, Novartis AG, Purdue Pharma L.P., and others are among the global leaders in Transdermal Drug Delivery System Market.
Which category dominates the transdermal drug delivery system market?
The pain management category is expected to have the greatest share of the market in transdermal drug delivery system products. One of the primary factors driving the segment's growth in the global market is the increased use of opioid medicine patches in pain treatment, particularly among cancer patients.
How is the regional performance of the transdermal drug delivery system market?
North America dominated the transdermal drug delivery system devices market until now, and this dominance is expected to remain at the top spot throughout the forecast period.